000 | 02162 a2200649 4500 | ||
---|---|---|---|
005 | 20250517184954.0 | ||
264 | 0 | _c20181015 | |
008 | 201810s 0 0 eng d | ||
022 | _a1365-2893 | ||
024 | 7 |
_a10.1111/jvh.12801 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrown, A | |
245 | 0 | 0 |
_aEfficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE study. _h[electronic resource] |
260 |
_bJournal of viral hepatitis _c05 2018 |
||
300 |
_a457-464 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAmides |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 |
_aBenzofurans _xadministration & dosage |
650 | 0 | 4 | _aCarbamates |
650 | 0 | 4 | _aCyclopropanes |
650 | 0 | 4 |
_aDrug Therapy, Combination _xadverse effects |
650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHepacivirus _xclassification |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aQuinoxalines _xadministration & dosage |
650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
650 | 0 | 4 | _aSulfonamides |
650 | 0 | 4 | _aSustained Virologic Response |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aHézode, C | |
700 | 1 | _aZuckerman, E | |
700 | 1 | _aFoster, G R | |
700 | 1 | _aZekry, A | |
700 | 1 | _aRoberts, S K | |
700 | 1 | _aLahser, F | |
700 | 1 | _aDurkan, C | |
700 | 1 | _aBadshah, C | |
700 | 1 | _aZhang, B | |
700 | 1 | _aRobertson, M | |
700 | 1 | _aWahl, J | |
700 | 1 | _aBarr, E | |
700 | 1 | _aHaber, B | |
773 | 0 |
_tJournal of viral hepatitis _gvol. 25 _gno. 5 _gp. 457-464 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/jvh.12801 _zAvailable from publisher's website |
999 |
_c27802906 _d27802906 |